CapForce Inc.
CFOR- Exchange
- OTC
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001293818
No open-market purchases or sales by CapForce Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding CapForce Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 17 | 13 | −4 |
| Shares | 293.8K | 464.5K | +170.7K (+58.1%) |
| Value | $123.7K | $322.1K | +$198.4K (+160.4%) |
New holders (3)
Institutions that held CapForce Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Chase Investment Counsel Corp | 331,890 | $230.0K | 0.09% |
| Boston Private Wealth LLC | 18,219 | $12.7K | 0.00% |
| BNP Paribas | 1 | $0 | 0.00% |
Sold out (7)
Institutions that held CapForce Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Renaissance Technologies LLC | 66,000 | $28.0K |
| Virtu Financial LLC | 40,384 | $17.0K |
| Citadel Advisors LLC | 36,377 | $15.3K |
| Connective Capital Management, LLC | 25,000 | $10.5K |
| Two Sigma Securities, LLC | 12,102 | $5.08K |
| Focused Wealth Management, Inc | 25 | $11 |
| BNP Paribas Arbitrage, SA | 1 | $0 |